216 related articles for article (PubMed ID: 35732116)
1. Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes.
Akter S; Chauhan KS; Dunlap MD; Choreño-Parra JA; Lu L; Esaulova E; Zúñiga J; Artyomov MN; Kaushal D; Khader SA
Cell Rep; 2022 Jun; 39(12):110983. PubMed ID: 35732116
[TBL] [Abstract][Full Text] [Related]
2. The source of Mycobacterium tuberculosis-specific IFN-γ production in peripheral blood mononuclear cells of TB patients.
Wang F; Mao L; Hou H; Wu S; Huang M; Yin B; Huang J; Zhu Q; Pan Y; Sun Z
Int Immunopharmacol; 2016 Mar; 32():39-45. PubMed ID: 26796515
[TBL] [Abstract][Full Text] [Related]
3. B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis.
Bénard A; Sakwa I; Schierloh P; Colom A; Mercier I; Tailleux L; Jouneau L; Boudinot P; Al-Saati T; Lang R; Rehwinkel J; Loxton AG; Kaufmann SHE; Anton-Leberre V; O'Garra A; Sasiain MDC; Gicquel B; Fillatreau S; Neyrolles O; Hudrisier D
Am J Respir Crit Care Med; 2018 Mar; 197(6):801-813. PubMed ID: 29161093
[TBL] [Abstract][Full Text] [Related]
4. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
Front Immunol; 2014; 5():180. PubMed ID: 24795723
[TBL] [Abstract][Full Text] [Related]
5. Cell-Mediated Immune Responses to
Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
Front Immunol; 2020; 11():103. PubMed ID: 32117257
[TBL] [Abstract][Full Text] [Related]
6. Antigens of
Choreño-Parra JA; Jiménez-Álvarez LA; Muñoz-Torrico M; Ramírez-Martínez G; Jiménez-Zamudio LA; Salinas-Lara C; García-Latorre EA; Zúñiga J
Front Immunol; 2020; 11():582414. PubMed ID: 33117393
[TBL] [Abstract][Full Text] [Related]
7. Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
[TBL] [Abstract][Full Text] [Related]
8. Lung type 3 innate lymphoid cells respond early following
Das S; Chauhan KS; Ahmed M; Akter S; Lu L; Colonna M; Khader SA
mBio; 2024 Apr; 15(4):e0329923. PubMed ID: 38407132
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of innate and adaptive lymphocytes during latent or active infection with Mycobacterium tuberculosis.
Ruiz-Sánchez BP; Castañeda-Casimiro J; Cabrera-Rivera GL; Brito-Arriola OM; Cruz-Zárate D; García-Paredes VG; Casillas-Suárez C; Serafín-López J; Chacón-Salinas R; Estrada-Parra S; Escobar-Gutiérrez A; Estrada-García I; Hernández-Solis A; Wong-Baeza I
Microbiol Immunol; 2022 Oct; 66(10):477-490. PubMed ID: 35856253
[TBL] [Abstract][Full Text] [Related]
10. Immunological basis of early clearance of Mycobacterium tuberculosis infection: the role of natural killer cells.
Abebe F
Clin Exp Immunol; 2021 Apr; 204(1):32-40. PubMed ID: 33315236
[TBL] [Abstract][Full Text] [Related]
11. Thinking Outside the Box: Innate- and B Cell-Memory Responses as Novel Protective Mechanisms Against Tuberculosis.
Choreño-Parra JA; Weinstein LI; Yunis EJ; Zúñiga J; Hernández-Pando R
Front Immunol; 2020; 11():226. PubMed ID: 32117325
[TBL] [Abstract][Full Text] [Related]
12. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
Abebe F
Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
[TBL] [Abstract][Full Text] [Related]
13. Spatial Resolution of
Magoulopoulou A; Qian X; Pediatama Setiabudiawan T; Marco Salas S; Yokota C; Rottenberg ME; Nilsson M; Carow B
Front Immunol; 2022; 13():876321. PubMed ID: 35663950
[No Abstract] [Full Text] [Related]
14. Interleukin-21 Regulates Natural Killer Cell Responses During Mycobacterium tuberculosis Infection.
Paidipally P; Tripathi D; Van A; Radhakrishnan RK; Dhiman R; Venkatasubramanian S; Devalraju KP; Tvinnereim AR; Valluri VL; Vankayalapati R
J Infect Dis; 2018 Mar; 217(8):1323-1333. PubMed ID: 29390153
[TBL] [Abstract][Full Text] [Related]
15. Functional and Phenotypic Changes of Natural Killer Cells in Whole Blood during
Garand M; Goodier M; Owolabi O; Donkor S; Kampmann B; Sutherland JS
Front Immunol; 2018; 9():257. PubMed ID: 29520269
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.
Koo MS; Manca C; Yang G; O'Brien P; Sung N; Tsenova L; Subbian S; Fallows D; Muller G; Ehrt S; Kaplan G
PLoS One; 2011 Feb; 6(2):e17091. PubMed ID: 21364878
[TBL] [Abstract][Full Text] [Related]
17. IL-22: An Underestimated Player in Natural Resistance to Tuberculosis?
Ronacher K; Sinha R; Cestari M
Front Immunol; 2018; 9():2209. PubMed ID: 30319650
[TBL] [Abstract][Full Text] [Related]
18. Mtb-specific CD27low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans.
Nikitina IY; Kondratuk NA; Kosmiadi GA; Amansahedov RB; Vasilyeva IA; Ganusov VV; Lyadova IV
PLoS One; 2012; 7(8):e43733. PubMed ID: 22937086
[TBL] [Abstract][Full Text] [Related]
19. Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics.
Dorhoi A; Yeremeev V; Nouailles G; Weiner J; Jörg S; Heinemann E; Oberbeck-Müller D; Knaul JK; Vogelzang A; Reece ST; Hahnke K; Mollenkopf HJ; Brinkmann V; Kaufmann SH
Eur J Immunol; 2014 Aug; 44(8):2380-93. PubMed ID: 24782112
[TBL] [Abstract][Full Text] [Related]
20. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
